{"id":"https://openalex.org/W2372024389","doi":null,"title":"The stakes in developing systemically active antibody therapeutics for CNS indications are exceedingly high ... The potential for opening CNS markets for a new class of therapeutics with high target selectivity and potency will continue to excite the development.","display_name":"The stakes in developing systemically active antibody therapeutics for CNS indications are exceedingly high ... The potential for opening CNS markets for a new class of therapeutics with high target selectivity and potency will continue to excite the development.","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2372024389","mag":"2372024389"},"language":"en","primary_location":{"id":"mag:2372024389","doi":null,"is_oa":false,"landing_page_url":"https://www.future-science.com/doi/pdf/10.4155/tde.15.78","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033240222","display_name":"Carl I. Webster","orcid":"https://orcid.org/0000-0003-2513-2256","observed_orcids":["https://orcid.org/0000-0003-2513-2256"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Carl I. Webster","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2513-2256","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5033240222"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.8230000138282776},{"id":"https://openalex.org/keywords/central-nervous-system-diseases","display_name":"central nervous system disorders","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cns-drug-development","display_name":"CNS drug development","score":0.7099999785423279},{"id":"https://openalex.org/keywords/target-selectivity","display_name":"target selectivity","score":0.8420000076293945}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6031230688095093},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.470800518989563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4432174861431122},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44158458709716797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41357362270355225},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34495097398757935},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24201473593711853},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12451863288879395},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09963274002075195}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2372024389","doi":null,"is_oa":false,"landing_page_url":"https://www.future-science.com/doi/pdf/10.4155/tde.15.78","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W206254588","https://openalex.org/W1574043141","https://openalex.org/W1973627211","https://openalex.org/W1992375147","https://openalex.org/W2025061302","https://openalex.org/W2042868277","https://openalex.org/W2089028453","https://openalex.org/W2096525076","https://openalex.org/W2100276489","https://openalex.org/W2109699895","https://openalex.org/W2125755807","https://openalex.org/W2137541358","https://openalex.org/W2144232916","https://openalex.org/W2149218172","https://openalex.org/W2157472739","https://openalex.org/W2159821105","https://openalex.org/W2162676548","https://openalex.org/W2222440515","https://openalex.org/W2261912426","https://openalex.org/W2396042072"],"related_works":["https://openalex.org/W1984138060","https://openalex.org/W7018313608","https://openalex.org/W2905767274","https://openalex.org/W421869784","https://openalex.org/W2931416517","https://openalex.org/W7017390919","https://openalex.org/W7073543258","https://openalex.org/W6922904800","https://openalex.org/W2189488905","https://openalex.org/W4231729788"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}